Article: Star Scientific Plans Worldwide Marketing and Sales of CigRx™ Nutraceutical in Partnership with inVentiv Health.

Oncimmune LLC, provider of EarlyCDT-Lung™, a simple blood test with the ability to aid physicians in the early detection of lung cancer, announced the appointment of two team members to strengthen its U.S. sales team, and further the company's efforts in advancing early cancer detection through proprietary autoantibody assay technologies. Oncimmune appointed John Rubin and Don Smyth as business development specialists. Based out of St. Louis, Mo., the new hires will report to vice president of commercial operations, Greg Stanley.

With these appointments, Oncimmune is positioned to advance its goal of increasing awareness of early cancer detection amongst the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!